Eli Lilly's drug candidate donanemab treating Alzheimer's disease has received breakthrough therapy status at the US Food and Drug Administration, according to a press release from Eli Lilly.
The coveted designation is given to drug candidates treating serious or life-threatening diseases with preliminary data indicating that this drug can significantly improve treatment opportunities.
Get full access for you and your coworkers.
Start a free company trial todayAlready a member? Log in.
More from MedWatch
GN Hearing top exec stops after 17 years – replacement found within own ranks
The CEO of hearing company GN Hearing's US subsidiary Audigy is now retiring after 17 years in the hot seat. The company, which was acquired by GN Hearing in 2016, has found his replacement within own ranks.
Pharma industry is discretely working against a global tax agreement
The pharmaceutical industry is fighting against a threat to companies' bottom lines: a global agreement which will harmonize corporation tax.
Pfizer upgrades guidance for sales of covid-19 vaccine
The US pharmaceutical company Pfizer now predicts sales of its coronavirus vaccines will total USD 33.5bn this year. The previous estimate was UDS 26bn. Meanwhile, the company has revealed the guidance for its annual revenue.
Astrazeneca shot shows no increased clot risk after two doses
Blot clots are not more likely after second Astrazeneca jab, data published in The Lancet suggests.
Boston Scientific reports significant growth in endoscopy business – grows 54 percent
In Q2, medtech firm Boston Scientific sold significantly more endoscopy products, which is the core business area of Danish company Ambu. The US giant is upgrading its guidance for the whole year.
Bio & Health Data Scientist - ALK-Abelló 
Analytical Coordinator - Symphogen 
Business developer within Medical Diagnostics 
We are expanding in CleanZone and we are looking for a technical product specialist and technical project manager 
Toxicologist - Lundbeck 
2 Account Managers, Merck Life Science - Best Talent 
Senior Biostatistician - Vaccibody 
KLIFO is looking for a Senior CMC Expert/Senior CMC Project Manager for our Copenhagen office 
Principal Scientist, Protein Drug Discovery & Development - Y-mAbs Therapeutics A/S 
Manager/Associate Director Regulatory Affairs - Ascendis Pharma 
Sponsor Oversight Lead - Genmab